SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-003753
Filing Date
2022-04-04
Accepted
2022-04-04 17:45:29
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 form4-04042022_020415.html 4  
1 form4-04042022_020415.xml 4 4146
  Complete submission text file 0001415889-22-003753.txt   5641
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Issuer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IDERA PHARMACEUTICALS, INC. 505 EAGLEVIEW BLVD., SUITE 212 EXTON PA 19341
Business Address
Kirby John J. (Reporting) CIK: 0001556327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31918 | Film No.: 22804117